{"id":"NCT01492101","sponsor":"Nektar Therapeutics","briefTitle":"The BEACON Study (Breast Cancer Outcomes With NKTR-102)","officialTitle":"The BEACON Study (Breast Cancer Outcomes With NKTR-102): A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 Versus Treatment of Physician's Choice (TPC) in Patients With Locally Recurrent or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane and Capecitabine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-12","primaryCompletion":"2016-04","completion":"2016-06","firstPosted":"2011-12-14","resultsPosted":"2021-06-01","lastUpdate":"2021-06-01"},"enrollment":852,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Locally Recurrent Breast Cancer","Metastatic Breast Cancer"],"interventions":[{"type":"DRUG","name":"NKTR-102","otherNames":[]},{"type":"DRUG","name":"Treatment of Physician's Choice (TPC)","otherNames":[]}],"arms":[{"label":"NKTR-102","type":"EXPERIMENTAL"},{"label":"Physician's Treatment of Choice","type":"ACTIVE_COMPARATOR"}],"summary":"The study is designed as an open-label, randomized, parallel, two arm, multicenter, international Phase 3 study in patients with recurrent or metastatic breast cancer previously treated with cytotoxic chemotherapy regimens.\n\nThe primary study objective is to compare overall survival of patients who receive NKTR-102 given once every 21 days to patients who receive treatment of Physician's Choice selected from a list of seven single-agent intravenous therapies.","primaryOutcome":{"measure":"Kaplan-Meier Estimate of Overall Survival: Intention to Treat (ITT) Population","timeFrame":"36 Months","effectByArm":[{"arm":"NKTR-102","deltaMin":12.4,"sd":null},{"arm":"Physician's Treatment of Choice","deltaMin":10.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"= 0.0835"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":10},"locations":{"siteCount":153,"countries":["United States","Belgium","Canada","France","Germany","Italy","Netherlands","Russia","South Korea","Spain","United Kingdom"]},"refs":{"pmids":["30957581","28612225","28360015","26482278"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":128,"n":425},"commonTop":["Nausea","Diarrhoea","Fatigue","Vomiting","Constipation"]}}